Pharma Marketing News
News & Views for
Responsible Marketers

Messages from Our Sponsors

Pharma Glossary

Pharmaguy's Picks

Pharma Marketing Network Curated Content Forums
The Leading Online Source of Curated Content for Pharmaceutical Marketing Experts
Newsletter | Conferences | Podcasts | Glossary | Surveys | Blog | Advertising Information | Contact Us

"Must Read Blog for Insiders." -- Wall Street Journal
Pharma Marketing News
Current Issue of Pharma Marketing News Available!

Search the Entire Pharma Marketing Forums Site

Go Back   Pharma Marketing Network Curated Content > News & Views > Industry News

Industry News Pharmaceutical industry news from newsfeeds, press releases, news stories, etc.

Thread Tools Rate Thread Display Modes
Old 14th July 2009, 03:57 PM
Pharma Newshound Pharma Newshound is offline
News Gatherer
Join Date: Dec 2007
Location: USA
Posts: 11,044
Default Pfizer Seeks 10-fold Rise in Global Cancer-Drug Sales by 2018


By Shannon Pettypiece and Naomi Kresge

Pfizer Inc. plans for its worldwide sales of medicines for treating cancer to increase 10-fold by 2018, said Andreas Penk, regional president of the company’s cancer business in Europe.

Pfizer, the world’s biggest drugmaker, had about $2.5 billion in cancer-medicine sales in 2008, according to the company. Pfizer plans to become the third-largest maker of cancer treatments, up from about seventh now, Penk said during a presentation in Berlin, without naming the other leaders. The sales goal is an internal projection and isn’t meant to serve as financial guidance, said Joan Campion, a spokeswoman for New York-based Pfizer.

“At the moment we’re about in seventh place in oncology,” said Penk, who is also head of Pfizer’s German operations. “We want to be in the top three in 2018. During this time we want to increase our sales by about 10 times.”

About a quarter of Pfizer’s 100 medicines in human testing are for cancer, according to the company’s listing on a Web site of its experimental products as of March 31. Pfizer plans to acquire rival drugmaker Wyeth for about $64 billion by the end of the year, gaining six cancer medicines in testing.

Cancer treatments were the top-selling category of medicine in 2008, generating $48.2 billion in sales last year, an 11.3 percent increase, according to data from IMS Health Inc. in Norwalk, Connecticut.

About half of Pfizer’s growth in cancer sales may come from Europe, Penk said. Pfizer pledged in 2007 to spend 20 percent of its more than $7 billion annual research budget on cancer.

To contact the reporters on this story: Shannon Pettypiece in New York at; Naomi Kresge in Berlin
Pharma Newshound
"I sift through the news so you don't have to!"

Please take the PMN Forums Visitor Survey and help us provide a better experience. It will only take 1 minute of your time.

Got news? Tell me about it:
Reply With Quote

Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump

All times are GMT -5. The time now is 01:25 PM.

Powered by vBulletin® Version 3.6.4
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
(c) 2014, Pharma Marketing Network. All rights reserved.